Tailored thoracomyoplasty as a valid treatment option for chronic post-lobectomy empyema

Détails

Ressource 1Télécharger: BIB_696DD8CAFFAD.P001.pdf (2776.14 [Ko])
Etat: Public
Version: Après imprimatur
ID Serval
serval:BIB_696DD8CAFFAD
Type
Thèse: thèse de doctorat.
Collection
Publications
Institution
Titre
Tailored thoracomyoplasty as a valid treatment option for chronic post-lobectomy empyema
Auteur⸱e⸱s
Fournier I.
Directeur⸱rice⸱s
Ris  H.-B.
Codirecteur⸱rice⸱s
Gonzalez  M.
Détails de l'institution
Université de Lausanne, Faculté de biologie et médecine
Adresse
Faculté de biologie et de médecineUniversité de LausanneUNIL - BugnonRue du Bugnon 21 - bureau 4111CH-1015 LausanneSUISSE
Statut éditorial
Acceptée
Date de publication
2012
Langue
anglais
Nombre de pages
24
Résumé
Background: Chronic post-lobectomy empyema is rare but may require space obliteration for infection control. We report our experience by using a tailored thoracomyoplasty for this specific indication with respect to infection control and functional outcome.
Patients and Methods: We retrospectively analysed 17 patients (11 men, 6 women) with chronic post-lobectomy empyema and treated by thoracomyoplasty in our institution between 2000 and 2011. All patients underwent an initial treatment attempt by use of chest tube drainage and antibiotics except those with suspicion of pleural aspergillosis (n=6). In 5 patients, bronchus stump insufficiency was identified at preoperative bronchoscopy. A tailored thoracoplasty was combined with a serratus anterior - rhomboid myoplasty which also served to close a broncho-pleural fistula, if present. The first rib was resected in 11/17 patients.
Results: The 90-day mortality was 11.7%. Thoracomyoplasty was successful in all surviving patients with respect to infection control, space obliteration and definitive closure of broncho-pleural fistula, irrespective of the type of infection, the presence of a broncho-pleural fistula and whether a 1st rib resection was performed . Post-lobectomy pulmonary function testing before and after thoracoplasty revealed a mean predicted FEV1 of 63.0±8.5% and 51.5±4.2% (p=0.01), and a mean predicted DLCO of 59.8±11.6% and 54.5±12.5%, respectively. Postoperative shoulder girdle dysfunction and scoliosis were prevented in patients willing to undergo intense physiotherapy.
Conclusions: Tailored thoracomyoplasty represents a valid option for patients with chronic post-lobectomy empyema without requiring a preceding open window thoracostomy. Space obliteration and infection control was equally obtained with and without first rib resection.
Création de la notice
27/09/2012 11:22
Dernière modification de la notice
20/08/2019 14:24
Données d'usage